[Mick Donoghue]

Sorry but there is not a generic equivalent to Esbriet (nor to Nintedanib). They are both fully patented and will be so for a few years. Either of these medicines sourced from a different manufacturer is going to be illegal definitely and not identical, likely. There is the possibility that a company’s pricing policy may mean that it is a bit cheaper in one country than another so maybe some saving could be made, but caveat emptor.